Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 348
Gene Symbol: APOE
APOE
0.200 Biomarker disease HPO
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.200 Biomarker disease HPO
Entrez Id: 5621
Gene Symbol: PRNP
PRNP
0.200 Biomarker disease HPO
Entrez Id: 5663
Gene Symbol: PSEN1
PSEN1
0.200 Biomarker disease HPO
Entrez Id: 54209
Gene Symbol: TREM2
TREM2
0.130 Biomarker disease HPO
Entrez Id: 5664
Gene Symbol: PSEN2
PSEN2
0.120 Biomarker disease HPO
Entrez Id: 10347
Gene Symbol: ABCA7
ABCA7
0.110 Biomarker disease HPO
Entrez Id: 2896
Gene Symbol: GRN
GRN
0.110 Biomarker disease HPO
Entrez Id: 25978
Gene Symbol: CHMP2B
CHMP2B
0.100 Biomarker disease HPO
Entrez Id: 7415
Gene Symbol: VCP
VCP
0.100 Biomarker disease HPO
Entrez Id: 203228
Gene Symbol: C9orf72
C9orf72
0.100 Biomarker disease HPO
Entrez Id: 54664
Gene Symbol: TMEM106B
TMEM106B
0.100 Biomarker disease HPO
Entrez Id: 43
Gene Symbol: ACHE
ACHE
0.020 Biomarker disease BEFREE <i>In vivo</i> localization of human acetylcholinesterase-derived species in a β-sheet conformation at the core of senile plaques in Alzheimer's disease. 30787102 2019
Entrez Id: 1113
Gene Symbol: CHGA
CHGA
0.010 Biomarker disease BEFREE <i>Rt</i> (10 <i>μ</i>g/ml) significantly inhibited the mean protein level of interleukin-1<i>β</i> (IL-1<i>β</i>) in the organotypic hippocampal slice cultures following treatment with chromogranin A (CGA, 10 nM) and pancreastatin (10 nM), endogenous microglial activators present in senile plaques. 29854069 2018
Entrez Id: 1081
Gene Symbol: CGA
CGA
0.010 Biomarker disease BEFREE <i>Rt</i> (10 <i>μ</i>g/ml) significantly inhibited the mean protein level of interleukin-1<i>β</i> (IL-1<i>β</i>) in the organotypic hippocampal slice cultures following treatment with chromogranin A (CGA, 10 nM) and pancreastatin (10 nM), endogenous microglial activators present in senile plaques. 29854069 2018
Entrez Id: 102
Gene Symbol: ADAM10
ADAM10
0.040 AlteredExpression disease BEFREE Neuritic plaques contain amyloid-β (Aβ) and lower levels of Aβ correspond to an increase in ADAM10 α-secretase activity. 22572541 2012
Entrez Id: 4504
Gene Symbol: MT3
MT3
0.010 AlteredExpression disease BEFREE Amyloid plaque burden and/or hAPP expression were decreased in the cortex and hippocampus of MT-3-deficient females. 22722772 2012
Entrez Id: 8803
Gene Symbol: SUCLA2
SUCLA2
0.100 Biomarker disease BEFREE Amyloid plaques composed of β-amyloid () protein are a pathological hallmark of Alzheimer's disease. 25946042 2015
Entrez Id: 831
Gene Symbol: CAST
CAST
0.010 Biomarker disease BEFREE Plaque pathology is not evident even when Aβ1-42 is increased by pharmacological manipulation (using calpain inhibitor 1), indicating that soluble Aβ species, or other APP processing products, are sufficient to cause the initial synaptic changes. 27287430 2016
Entrez Id: 5502
Gene Symbol: PPP1R1A
PPP1R1A
0.010 Biomarker disease BEFREE Plaque pathology is not evident even when Aβ1-42 is increased by pharmacological manipulation (using calpain inhibitor 1), indicating that soluble Aβ species, or other APP processing products, are sufficient to cause the initial synaptic changes. 27287430 2016
Entrez Id: 351
Gene Symbol: APP
APP
0.400 Biomarker disease BEFREE Plaque pathology is not evident even when Aβ1-42 is increased by pharmacological manipulation (using calpain inhibitor 1), indicating that soluble Aβ species, or other APP processing products, are sufficient to cause the initial synaptic changes. 27287430 2016
Entrez Id: 5621
Gene Symbol: PRNP
PRNP
0.200 Biomarker disease BEFREE Neuritic plaques characteristic of AD were once thought to be exclusively associated with beta-A4 amyloid; however, some pedigrees with familial prion disease produced neuritic plaques with PrP amyloid cores. 7904883 1993
Entrez Id: 836
Gene Symbol: CASP3
CASP3
0.040 Biomarker disease BEFREE Caspase-3 is the predominant caspase involved in APP cleavage, consistent with its marked elevation in dying neurons of Alzheimer's disease brains and colocalization of its APP cleavage product with A beta in senile plaques. 10319819 1999
Entrez Id: 2
Gene Symbol: A2M
A2M
0.010 Biomarker disease BEFREE Alpha-2-macroglobulin (A2M) is a proteinase inhibitor that is present in senile plaques and may play a role in metabolism of amyloid beta (A beta) peptide. 10477119 1999
Entrez Id: 6622
Gene Symbol: SNCA
SNCA
0.080 Biomarker disease BEFREE Alpha synuclein also contributes to the intracellular inclusions of multiple system atrophy, and a fragment has been found in senile plaques in Alzheimer's disease. 10491577 1999